JT Pharma (Kappa Opiod)

Business Data, Corporate Office and Headquarter Address

About

JT Pharma (Kappa Opiod) is Buildings and Property in United States that focus on Portfolio business. They cover business area such as Portfolio, kappa, agonist peptide.

Business Type

Buildings and Property

Country

United States

Founded

-

Company Focus

Portfolio

Website

-

Corporate Office and Headquarter Office address:

Mount Pleasant, SC 29464
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

Portfoliokappaagonist peptide

* We use standard office opening hours in near JT Pharma (Kappa Opiod)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

JT Pharma (Kappa Opiod) Frequently Asked Questions

What or who is JT Pharma (Kappa Opiod)?

JT Pharma (Kappa Opiod) is Buildings and Property business from United States that founded in - ( years old in ), JT Pharma (Kappa Opiod) business is focusing on Portfolio.

Where is JT Pharma (Kappa Opiod) headquarter and corporate office address?

JT Pharma (Kappa Opiod) headquarter office and corporate office address is located in Mount Pleasant, SC 29464 United States.

Where is JT Pharma (Kappa Opiod) country origins?

JT Pharma (Kappa Opiod) was founded in United States.

What is Portfolio business focus on?

In , JT Pharma (Kappa Opiod) is currently focus on Portfolio sector.

Disclaimer: This website is not affiliated with JT Pharma (Kappa Opiod), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.